662111-36-6Relevant articles and documents
Design driven HtL: The discovery and synthesis of new high efficacy β2-agonists
Stocks, Michael J.,Alcaraz, Lilian,Bailey, Andrew,Bonnert, Roger,Cadogan, Elaine,Christie, Jadeen,Connolly, Stephen,Cook, Anthony,Fisher, Adrian,Flaherty, Alice,Hill, Stephen,Humphries, Alexander,Ingall, Anthony,Jordan, Stephen,Lawson, Mandy,Mullen, Alex,Nicholls, David,Paine, Stuart,Pairaudeau, Garry,St-Gallay, Stephen,Young, Alan
, p. 4027 - 4031 (2011/08/06)
The design and synthesis of a new series of high efficacy β2-agonists devoid of the key benzylic alcohol present in previously described highly efficacious β2-agonists is reported. A hypothesis for the unprecedented level of efficacy is proposed based on considerations of β2-adrenoceptor crystal structure, other biophysical data and modeling studies.
MEDICINAL COMPOUNDS
-
Page 43, (2010/02/06)
The present invention concerns compounds of formula (I) and salts, solvates, and physiologically functional derivatives thereof, wherein: R1 is hydrogen or -XSO2NR6R7; R2 and R3 are indepen